Key facts
- It has raised $150K; the latest was Later Stage VC ($150K) in Jun 2025.
- Notable investors include Innovation Works, LifeX Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for SignatureDx
- ·The full record, as it builds
Funding rounds
No funding rounds for SignatureDx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SignatureDx
Operator of a bioanalytical platform intended to detect and monitor silently progressing complex human diseases. The company specializes in novel methods of prediction and treatment of human disease through non-invasive diagnostic testing, enabling individuals to reduce organ diseases and get successful treatment.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2020
- Employees
- 20
- Website
- signaturedx.com/
- Ownership
- Privately Held (backing)
SignatureDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SignatureDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SignatureDx in its N-PORT filings yet. We sweep new filings monthly.